These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


148 related items for PubMed ID: 9637502

  • 1. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
    Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF.
    J Immunol; 1998 Jun 15; 160(12):5898-906. PubMed ID: 9637502
    [Abstract] [Full Text] [Related]

  • 2. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
    Yi AK, Hornbeck P, Lafrenz DE, Krieg AM.
    J Immunol; 1996 Dec 01; 157(11):4918-25. PubMed ID: 8943396
    [Abstract] [Full Text] [Related]

  • 3. CpG-oligodeoxynucleotide protects immune cells from gamma-irradiation-induced cell death.
    Sohn WJ, Lee KW, Choi SY, Chung E, Lee Y, Kim TY, Lee SK, Choe YK, Lee JH, Kim DS, Kwon HJ.
    Mol Immunol; 2006 Mar 01; 43(8):1163-71. PubMed ID: 16122803
    [Abstract] [Full Text] [Related]

  • 4. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep 01; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 5. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK, Rasmussen WL, Krieg AM.
    J Immunol; 1996 Sep 01; 157(5):1840-5. PubMed ID: 8757300
    [Abstract] [Full Text] [Related]

  • 6. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G.
    J Leukoc Biol; 2002 Jul 01; 72(1):83-92. PubMed ID: 12101266
    [Abstract] [Full Text] [Related]

  • 7. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E, Berg M, Magnusson M.
    Vet Immunol Immunopathol; 2005 Sep 15; 107(3-4):265-79. PubMed ID: 15955566
    [Abstract] [Full Text] [Related]

  • 8. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
    Lenert P, Stunz L, YI AK, Krieg AM, Ashman RF.
    Antisense Nucleic Acid Drug Dev; 2001 Aug 15; 11(4):247-56. PubMed ID: 11572601
    [Abstract] [Full Text] [Related]

  • 9. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.
    Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM.
    J Immunol; 1996 Dec 15; 157(12):5394-402. PubMed ID: 8955187
    [Abstract] [Full Text] [Related]

  • 10. Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
    Naderi S, Blomhoff R, Myklebust J, Smeland EB, Erikstein B, Norum KR, Blomhoff HK.
    Exp Cell Res; 1999 Oct 10; 252(1):144-53. PubMed ID: 10502407
    [Abstract] [Full Text] [Related]

  • 11. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
    Macfarlane DE, Manzel L, Krieg AM.
    Immunology; 1997 Aug 10; 91(4):586-93. PubMed ID: 9378499
    [Abstract] [Full Text] [Related]

  • 12. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS, Askew D, Noss EH, Tobian A, Krieg AM, Harding CV.
    J Immunol; 1999 Aug 01; 163(3):1188-94. PubMed ID: 10415013
    [Abstract] [Full Text] [Related]

  • 13. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA.
    Kim D, Rhee JW, Kwon S, Sohn WJ, Lee Y, Kim DW, Kim DS, Kwon HJ.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):362-7. PubMed ID: 19103173
    [Abstract] [Full Text] [Related]

  • 14. CpG motifs in bacterial DNA trigger direct B-cell activation.
    Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM.
    Nature; 1995 Apr 06; 374(6522):546-9. PubMed ID: 7700380
    [Abstract] [Full Text] [Related]

  • 15. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW, Huang HC.
    Br J Pharmacol; 1998 Jul 06; 124(6):1029-40. PubMed ID: 9720770
    [Abstract] [Full Text] [Related]

  • 16. Antimetastatic effect of CpG DNA mediated by type I IFN.
    Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel DN.
    Cancer Res; 2001 Jul 15; 61(14):5523-8. PubMed ID: 11454702
    [Abstract] [Full Text] [Related]

  • 17. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GN, Schwindt TT, Armelin HA.
    J Mol Endocrinol; 2004 Dec 15; 33(3):623-38. PubMed ID: 15591023
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
    Macfarlane DE, Manzel L.
    J Immunol; 1998 Feb 01; 160(3):1122-31. PubMed ID: 9570525
    [Abstract] [Full Text] [Related]

  • 19. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes.
    Sabourin LA, Hawley RG.
    J Cell Physiol; 1990 Dec 01; 145(3):564-74. PubMed ID: 1703172
    [Abstract] [Full Text] [Related]

  • 20. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR, Zhu F, Li Y, Bhagat L, Cong Y, Kandimalla ER, Agrawal S.
    Nucleic Acids Res; 2006 Dec 01; 34(11):3231-8. PubMed ID: 16798912
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.